Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,695 | 2,790 | 1,348 | 4,346 | 6,174 |
| Receivables | 934 | 333 | 119 | 51 | 46 |
| Inventories | 97 | 151 | 192 | N/A | N/A |
| TOTAL | $2,769 | $3,313 | $1,686 | $4,472 | $6,269 |
| Non-Current Assets | |||||
| PPE Net | 59 | 51 | 55 | 57 | 46 |
| Intangibles | 313 | 362 | 415 | 468 | 521 |
| Other Non-Current Assets | 55 | 59 | 64 | 68 | 40 |
| TOTAL | $427 | $472 | $534 | $593 | $607 |
| Total Assets | $3,196 | $3,785 | $2,220 | $5,065 | $6,876 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,750 | 2,750 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,878 | 1,713 | 1,629 | 2,947 | 2,892 |
| Accrued Expenses | 1,038 | 955 | 887 | 1,382 | 1,089 |
| Other current liabilities | 7,000 | 6,487 | 5,966 | 5,446 | 4,941 |
| TOTAL | $12,905 | $12,190 | $14,267 | $12,872 | $14,769 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,750 | N/A |
| Deferred Revenues | 239 | 285 | 285 | 347 | 347 |
| Other Non-Current Liabilities | 7,656 | 5,937 | 8,085 | 9,173 | 10,515 |
| TOTAL | $10,454 | $9,201 | $11,420 | $16,132 | $14,811 |
| Total Liabilities | $23,359 | $21,391 | $25,687 | $29,004 | $29,580 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19 | 19 | 19 | 16 | 16 |
| Common Shares | 241 | 239 | 195 | 194 | 193 |
| Retained earnings | -260,773 | -255,441 | -255,275 | -255,178 | -253,472 |
| Other shareholders' equity | -4 | -4 | -4 | -4 | -4 |
| TOTAL | $-20,163 | $-17,606 | $-23,467 | $-23,939 | $-22,704 |
| Total Liabilities And Equity | $3,196 | $3,785 | $2,220 | $5,065 | $6,876 |